Clinical nodal staging scores for prostate cancer: a proposal for preoperative risk assessment.

• Kluth LA 1] Department of Urology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA [2] Department of Urology, University Medical-Center Hamburg-Eppendorf, Hamburg, Germany.
• Abdollah F Department of Urology, Vita-Salute San Raffaele University, Milan, Italy.
• Xylinas E 1] Department of Urology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA [2] Department of Urology, Cochin Hospital, Assistance Publique-Hopitaux de Paris, Paris Descartes University, Paris, France.
• Rieken M 1] Department of Urology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA [2] Department of Urology, University Hospital of Basel, Basel, Switzerland.
• Fajkovic H Department of Urology, Medical University of Vienna, Vienna, Austria.
• Seitz C Department of Urology, Medical University of Vienna, Vienna, Austria.
• Sun M Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada.
• Karakiewicz PI Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada.
• Schramek P Department of Urology, Krankenhaus der Barmherzigen Brueder, Vienna, Austria.
• Herman MP Department of Urology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA.
• Becker A Department of Urology, University Medical-Center Hamburg-Eppendorf, Hamburg, Germany.
• Hansen J Prostate Cancer Center, Martini-Clinic, Hamburg, Germany.
• Ehdaie B Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
• Loidl W Prostate Cancer Center, Krankenhaus Barmherzige Schwestern Linz, Linz, Austria.
• Pummer K Department of Urology, Medical University of Graz, Graz, Austria.
• Lee RK Department of Urology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA.
• Lotan Y Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
• Scherr DS Department of Urology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA.
• Seiler D Department of Urology, Kantonsspital Aarau, Aarau, Switzerland.
• Ahyai SA Department of Urology, University Medical-Center Hamburg-Eppendorf, Hamburg, Germany.
• Chun FK Department of Urology, University Medical-Center Hamburg-Eppendorf, Hamburg, Germany.
• Graefen M Prostate Cancer Center, Martini-Clinic, Hamburg, Germany.
• Tewari A Department of Urology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA.
• Nonis A CUSSB (University Centre for Statistics in the Biomedical Sciences), Vita-Salute San Raffaele University, Milan, Italy.
• Bachmann A Department of Urology, University Hospital of Basel, Basel, Switzerland.
• Montorsi F Department of Urology, Vita-Salute San Raffaele University, Milan, Italy.
• Gönen M Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
• Briganti A Department of Urology, Vita-Salute San Raffaele University, Milan, Italy.
• Shariat SF 1] Department of Urology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA [2] Department of Urology, Medical University of Vienna, Vienna, Austria [3] Division of Medical Oncology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA.

Show more…

Aged

Aged, 80 and over

Cohort Studies

Humans

Lymph Node Excision

Lymphatic Metastasis

Male

Middle Aged

Neoplasm Staging

Prostatectomy

Prostatic Neoplasms

Risk Assessment